1Ferrara N,Henzel WJ.Pituitary follicular cells secrete a novel he-parin-binding growth factor specific for vascular endothelial cells.Biochem Biophys Res Commun,1989,161(2):851-858.
2Neufeld G,Kesslor O,Herzog Y.The interaction of neuropilin-1 and neuropilin-2 with tyrosine-kinase receptors for VEGF.Adv Exp Med Biol,2002,515:81-90.
3Brock AA,Ranganathan S,Abounader R,et al.Scatter factor/hepatocyte growth factor gene transfer increases rat blood glioma barrier permeability.Brain Res,1999,833(2):173-180.
4Gabriovich DJ,Chen HL,Girgis KR,et al.Production of vascular endothelial growth factor by human tumors inhibits the functional ma-turation of dentitic cells.Nat Med,1996,2(10):1096-1103.
5Kliche S,Waltenberger J.VEGF receptor signaling and endothelial function.IU BMB Life,2001,52(1/2):61-66.
6Gliki G,Wheeler-Jones C,Zachary I,et al.Vascular endothelial growth factor induces protein kinase C (PKC) dependent Akt/PKB activation and phosphatidylinositol 3-kinase-mediates PKC delta phosphorylation:role of PKC in angiogenesis.Cell Biol Int,2002,26(9):751-759.
7Zachary I,Gliki G.Sigaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.Cardiovasc Res,2001,49(3):568-581.
8Yahata Y,Shirakata Y,Tokumaru S,et al.Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor induced human dermal microvascular endothelial cell migration and tube formation.J Biol Chem,2003,278(41):40026-40031.
9Yamauchi-Takihara K,Kishimoto T.A novel role for STAT3 in cardiac remodeling.Trends Cardiovasc Med,2000,10(7):298-303.
10Nelson NJ.Inhibitors of angiogenesis enter phase Ⅲ testing.J Natl Cancer Inst,1998,90(13):960-963.
